MAPK3 and acute lymphoblastic leukemia: When sensitive T-ALL cells were treated for a short period with PIM inhibitors (Figure 4A), phosphorylation of STAT5 and ERK1/2 was increased, suggesting that signaling pathways were being activated in response to these inhibitors.